Exploring new perspectives to make extraordinary discoveries

At Montara, we’re developing safer, more efficacious therapies to improve the lives of patients with neurological diseases.

Our mission is to develop innovative therapies for diseases of the brain by leveraging our proprietary platform to enhance safety and efficacy to enable pharmacological drugging of established targets.

Introducing BrainOnly™, the uniquely versatile platform designed to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain, enhancing safety, increasing therapeutic index, and improving efficacy

Many promising drug candidates for neurological diseases fail to advance due to dose-limiting, off-tissue peripheral toxicities, which impede both safety and efficacy.

BrainOnly is a breakthrough platform that aims to prevent peripheral adverse events associated with neuroscience drugs. It holds the potential to deliver a new generation of brain-targeted therapeutics.

Access many currently undruggable targets and enhance the profile of existing drugs

Utilize with novel or existing small molecule inhibitors or activators

Broad applicability across neurodegenerative and neurological diseases and brain cancer

Learn more about our science  

Solid experience with a fresh perspective

Solid experience with a fresh perspective

We are Montara Therapeutics, a precision medicine neuroscience biotech startup based in San Francisco. Our experienced team has founded successful biotech companies, and we are supported by world-class scientific and chemistry advisory boards.

We present a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.

Learn more about our team  

Meet us in person

Upcoming Scientific Meetings

American Epilepsy Society Annual Meeting 

December 5-9, 2025   |   Atlanta, GA

Autophagy: Mechanisms to Therapy (Keystone Conference) 

February 2-5, 2026   |   Keystone, CO

AD/PD™ Alzheimer’s Disease and Parkinson’s Disease Conference 

March 17-21, 2026   |   Copenhagen, Denmark

American Academy of Neurology Annual Meeting 

April 18-22, 2026   |   Chicago, IL

Neurodegeneration (Keystone Conference) 

June 22-25, 2026   |   Whistler, BC, Canada

Upcoming Investor/Partnering Meetings

Wilson Sonsini Biotech Summit 

October 22-23, 2025   |   Boston, MA

Biocom California CEO Summit 

October 24, 2025   |   Napa Valley, CA

SV Health Investors Forum

November 15-17, 2025   |   London, UK

Jefferies London Healthcare Conference 

November 18-20, 2025   |   London, UK

J.P. Morgan 44th Annual Healthcare Conference 

January 12-15, 2026   |   San Francisco, CA

Biocom Global Life Science Partnering & Investor Conference 

February 24-26, 2026   |   La Jolla, CA

BIO International Convention 

June 22-25, 2026   |   San Diego, CA

Get in touch with Montara

Learn about opportunities with us, and sign up to receive news and updates.

Get in touch with Montara

Learn about opportunities with us, and sign up to receive news and updates.


Message frequency may vary. You may opt out at any time. Privacy Policy and Terms of Use

Get in touch with Montara

Learn about opportunities with us, and sign up to receive news and updates.


Message frequency may vary. You may opt out at any time. Privacy Policy and Terms of Use